| 1 |
34197589 | Impaired Learning From Negative Feedback in Stimulant Use Disorder: Dopaminergic Modulation. | 2021 Nov 12 |
1 |
| 2 |
25679126 | DRD2 genotypic and haplotype variation is associated with improvements in negative symptoms after 6 weeks' amisulpride treatment. | 2015 Apr |
4 |
| 3 |
21289169 | Dopamine-mediated reinforcement learning signals in the striatum and ventromedial prefrontal cortex underlie value-based choices. | 2011 Feb 2 |
1 |
| 4 |
21663752 | Differential effects of amisulpride and haloperidol on dopamine D2 receptor-mediated signaling in SH-SY5Y cells. | 2011 Sep |
1 |
| 5 |
21670104 | Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. | 2011 Sep |
1 |
| 6 |
17285098 | Atypical antipsychotics and pituitary neoplasms in the WHO database. | 2007 |
1 |
| 7 |
16288681 | The antipsychotic sultopride is overdosed--a PET study of drug-induced receptor occupancy in comparison with sulpiride. | 2006 Oct |
1 |
| 8 |
11873706 | Atypical antipsychotics: mechanism of action. | 2002 Feb |
1 |
| 9 |
12165366 | SPECT imaging, clinical features, and cognition before and after low doses of amisulpride in schizophrenic patients with the deficit syndrome. | 2002 Aug 20 |
1 |
| 10 |
23573604 | The role of limbic and cortical regions in schizophrenia: focus on dopamine. | 2002 Aug |
1 |
| 11 |
11270918 | In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia. | 2001 Apr |
1 |
| 12 |
9892856 | Amisulpride versus amineptine and placebo for the treatment of dysthymia. | 1999 |
1 |
| 13 |
10200742 | Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group. | 1999 Apr |
1 |
| 14 |
9165379 | Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group. | 1997 Apr |
1 |
| 15 |
8935811 | In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia. | 1996 Mar |
1 |
| 16 |
7802104 | Improvement of some schizophrenic deficit symptoms with low doses of amisulpride. | 1995 Jan |
1 |